We are live on ! Find out more
OCGN icon

Ocugen

122 hedge funds and large institutions have $291M invested in Ocugen in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 28

5% more funds holding

Funds holding: 116122 (+6)

4.35% more ownership

Funds ownership: 27.78%32.13% (+4.3%)

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

15% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $20.1M

27% less capital invested

Capital invested by funds: $396M → $291M (-$106M)

Holders
122
Holders Change
+6
Holders Change %
+5.17%
% of All Funds
1.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
36
Reduced
34
Closed
28
Calls
$17.1M
Puts
$20.1M
Net Calls
-$2.96M
Net Calls Change
-$15.2M

OCGN Hedge Fund Activity: Q4 2021 in Review

122 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q4 2021, worth a combined $291M — down 27% from $396M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new OCGN positions and 28 closed out — a net gain of 6 holders — while 36 added to existing stakes and 34 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $20.9M. The largest seller was Valiant Capital Management, exiting entirely with an estimated $11.4M sold.

  • 122 institutional investors held Ocugen (OCGN) as of Q4 2021, up from 116 in Q3 2021.
  • Funds reported $291M of Ocugen stock for Q4 2021, down 27% quarter-over-quarter.
  • 34 funds opened new Ocugen positions in Q4 2021 and 28 closed out, a net change of +6 holders.
  • The largest Ocugen buyer in Q4 2021 was JP Morgan Chase, an estimated $20.9M added.
  • The largest Ocugen seller in Q4 2021 was Valiant Capital Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.